文献速递脑血管病

急性缺血性卒中成功再灌注后梗死周围微血管血流动力学恶化预测梗死增长

Deterioration of Peri-Infarct Microvascular Hemodynamics Following Successful Reperfusion in Acute Ischemic Stroke Predicts Infarct Growth.
PubMed 文献 · Stroke · 2026-09-28

该回顾性病例对照研究纳入47例成功再灌注的急性缺血性卒中患者,在血栓切除术后即刻灌注MRI上测量梗死周围毛细血管通过时间相对异质性(RTH)。结果发现梗死周围RTH升高独立预测梗死增长≥10 mL和90天功能预后不良,提示微血管功能障碍可能是无复流现象的标志。

要点

  • 成功再灌注后梗死周围RTH升高与梗死增长≥10 mL独立相关。
  • 梗死周围RTH升高独立预测90天功能预后不良(mRS>2)。
  • RTH可能作为大血管再通后微血管无复流的影像标志物。

核心结论

  • 血栓切除术后即刻MRI上梗死周围RTH升高预测成功再灌注的急性缺血性卒中患者发生显著梗死增长和功能预后不良。
  • 结果提示RTH升高的微血管功能障碍可能是尽管大血管再灌注良好但仍出现无复流现象的潜在标志。

研究设计与样本

  • 加州大学洛杉矶分校的回顾性病例对照研究,纳入2015至2020年急性缺血性卒中患者。
  • 纳入标准为改良脑梗死溶栓评分≥2c的优异再灌注,且有基线、血栓切除术后即刻和术后24至48小时的弥散及灌注加权MRI。
  • 梗死周围区域定义为基线MRI上达峰时间≥6秒且术后即刻MRI上非梗死区域;共47例患者纳入分析(62%女性;平均年龄72±13岁;中位NIHSS评分14)。

主要发现

  • 47例患者中20例(43%)出现显著梗死增长和功能预后不良。
  • 梗死增长>10 mL的患者梗死周围RTH显著更高(P=0.005),且为独立预测因子(每增加10%的比值比1.4,95%CI 1.0-2.0;P=0.04)。
  • 功能预后不良的患者梗死周围RTH显著更高(P<0.001),且为功能预后不良的显著预测因子(每增加10%的比值比1.4,95%CI 1.0-1.9;P=0.03)。

临床怎么用

  • 对于大血管成功再灌注的急性缺血性卒中患者,术后即刻灌注MRI测量的梗死周围RTH可帮助识别梗死增长和功能预后不良的高风险个体。
  • RTH作为微血管无复流的潜在影像标志物,可能辅助临床决策,但需进一步验证。

局限性

  • 回顾性病例对照设计,样本量较小(47例),可能存在选择偏倚。
  • 单中心研究,结果外推需谨慎。
  • 未报告RTH测量的可重复性或外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Microvascular hemodynamic deterioration is a proposed mechanism underlying the no-reflow phenomenon in acute ischemic stroke. Experimental studies suggested that relative heterogeneity of capillary transit time (RTH) is a potential imaging biomarker of microvascular impairment. We investigated the relationship between peri-infarct RTH and infarct growth, measured on immediate post-thrombectomy (PT) perfusion magnetic resonance imaging (MRI), and functional outcomes in patients with acute ischemic stroke with successful reperfusion. METHODS: In this retrospective case-control study from the University of California, Los Angeles, patients with acute ischemic stroke from 2015 to 2020 were included if they had excellent reperfusion (modified Thrombolysis in Cerebral Infarction score ≥2c) and diffusion- and perfusion-weighted MRIs at baseline, immediately PT, and 24 to 48 hours after thrombectomy. Peri-infarct regions were defined as time to maximum ≥6-second regions on baseline MRI that were not infarcted on immediate PT MRI. Following image coregistration, quantitative values of perfusion parameters, including RTH, were obtained from peri-infarct regions on immediate PT MRI. Two primary outcomes were assessed: (1) infarct growth ≥10 mL and (2) poor functional outcome (90-day modified Rankin Scale score >2). Associations between clinical and imaging parameters and outcomes were evaluated using univariate analysis. Age, sex, and covariates that were significant in univariate analysis were included in logistic regression analyses. RESULTS: Among 47 patients included in the analysis (62% women; mean age, 72±13 years; median National Institutes of Health Stroke Scale score, 14), 20 (43%) patients had substantial infarct growth and poor functional outcome. Peri-infarct RTH was significantly (P=0.005) higher in patients with infarct growth >10 mL than those without and remained as an independent predictor (odds ratio, 1.4 per 10% increase [95% CI, 1.0-2.0]; P=0.04). Similarly, the peri-infarct RTH was significantly higher (P<0.001) in patients with poor functional outcomes than those with good functional outcomes and remained as a significant predictor of poor functional outcome (odds ratio, 1.4 per 10% increase [95% CI, 1.0-1.9]; P=0.03). CONCLUSIONS: Increased peri-infarct RTH on immediate PT MRI predicts substantial infarct growth and poor functional outcomes in successfully reperfused patients with acute ischemic stroke. Results highlight the role of microvascular dysfunction depicted by elevated RTH as a potential marker of no-reflow phenomenon despite excellent macrovascular reperfusion.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Yu Y, Asghariahmadabad M, Mahmoudi K, et al. Deterioration of Peri-Infarct Microvascular Hemodynamics Following Successful Reperfusion in Acute Ischemic Stroke Predicts Infarct Growth. Stroke. 2026. PMID: 42803008. doi:10.1161/STROKEAHA.126.056258

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。